Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 13, 1989 - Issue 6
23
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Hb Chad or α223(B4)GLU→LYSβ2 Observed in Members of a Surinam Family in Association with α-Thalassemia-2 and with HB S

, , , , , & show all
Pages 543-556 | Received 28 Apr 1989, Accepted 17 Jul 1989, Published online: 07 Jul 2009
 

Abstract

Three different hemoglobinopathies, i.e. Hb S, Hb Chad [α23 (B4)Glu→Lys], and α-thalassemia-2 (−3.7) have been observed in eight members of a family from Surinam. The proposita had all three abnormalities, while her mother and four of her half-brothers had Hb Chad together with an α-thalassemia-2 heterozygosity or homozygosity. Gene mapping and dot-blot analysis of amplified DNA identified a G→A mutation in codon 23 of the α2αl hybrid gene resulting in the Glu→Lys substitution. The quantity of the α-Chad chain averaged 31.5% in its carriers with an additional α-thalassemia-2 heterozygosity [-αCnad(−3.7 kb)/ α α], and 43% in the two carriers with an additional α-thalassemia-2 homozygosity [-αChad(−3.7 kb)/- α (3.7 kb)]. These quantities are considerably higher than those reported for families from Chad, China, and Japan; the low levels of 14.5-24% Hb Chad in members of previously reported cases suggest a mutation on a chromosome with two α-globin genes [α αChad/α α or αChadα/ α α].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.